NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 21 filers reported holding NOVUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | -71.4% | 4,067 | -65.5% | 0.00% | – |
| Q3 2019 | $7,000 | -82.5% | 11,773 | -70.9% | 0.00% | – |
| Q2 2019 | $40,000 | -45.2% | 40,452 | +120.6% | 0.00% | – |
| Q1 2019 | $73,000 | -9.9% | 18,338 | -63.9% | 0.00% | – |
| Q4 2018 | $81,000 | -88.1% | 50,846 | -65.1% | 0.00% | – |
| Q3 2018 | $680,000 | +10.7% | 145,801 | +66.1% | 0.00% | – |
| Q2 2018 | $614,000 | +3511.8% | 87,799 | +2375.3% | 0.00% | – |
| Q1 2018 | $17,000 | – | 3,547 | +88575.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 4 | -98.7% | 0.00% | – |
| Q3 2017 | $1,000 | -94.4% | 315 | -90.4% | 0.00% | – |
| Q2 2017 | $18,000 | – | 3,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 90,199 | $421,000 | 0.26% |
| Boxer Capital, LLC | 324,383 | $1,515,000 | 0.17% |
| Orbimed Advisors | 2,537,110 | $11,848,000 | 0.14% |
| RTW INVESTMENTS, LP | 316,257 | $1,477,000 | 0.09% |
| B. Riley Wealth Advisors, Inc. | 45,000 | $211,000 | 0.02% |
| Sequoia Financial Advisors, LLC | 17,500 | $82,000 | 0.01% |
| Renaissance Technologies | 251,556 | $1,175,000 | 0.00% |
| VANGUARD GROUP INC | 135,599 | $633,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 12,499 | $58,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 10,944 | $51,000 | 0.00% |